Lifecome Biochemistry (002868) announced on the evening of December 6th that recently, its controlling shareholder Shanghai Kangyi transferred its 11.4 million shares of the company's unrestricted tradable shares back from Guotai Junan Securities Co., Ltd.'s customer credit trading-guaranteed securities account to a regular securities account (the ownership of these shares has not changed), thereby terminating the aforementioned finance and securities lending business. As of the date of this announcement, Shanghai Kangyi holds 47.2914 million shares of the company (all of which are unrestricted tradable shares), accounting for 30.43% of the total share capital of the company, all stored in a regular securities account.